Filing search / Olema Pharmaceuticals, Inc. / "Responsible"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Responsible"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

80 results

Newest first Best match first

10-Q

2024 Q2

EX-31.2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

presented in this report; 4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

6 Aug 24

4:15pm

10-Q

2024 Q2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

will be responsible for the conduct of the clinical trials for the combined therapies in accordance with a mutually agreed development plan. As part … those specific to each component study drug), will be jointly owned by the parties. The Company is responsible for manufacturing, packaging

6 Aug 24

4:15pm

10-Q

2024 Q2

EX-31.1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

in this report; 4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

6 Aug 24

4:15pm

10-Q

2024 Q1

EX-31.1

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

in this report; 4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

8 May 24

4:15pm

10-Q

2024 Q1

EX-31.2

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

presented in this report; 4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls

8 May 24

4:15pm

10-Q

68m0 57mnux

Quarterly report

8 May 24

4:15pm

DEF 14A

4dge pcn29kz7u

Definitive proxy

26 Apr 24

5:07pm

10-K

1kx iue5ibatqk6i5jh

Annual report

11 Mar 24

4:15pm

11 Mar 24

4:15pm

11 Mar 24

4:15pm

424B3

gyv9qlcq

12 Feb 24

Prospectus supplement

31 Jan 24

4:21pm

424B5

dbt6iboz squnx94jk

5 Jan 24

Prospectus supplement for primary offering

7 Nov 23

4:12pm

10-Q

67qz4efapjfc

Quarterly report

7 Nov 23

4:12pm

7 Nov 23

4:12pm

Olema Oncology Announces Combined Financing for Up to $180 Million

Olema Oncology Announces Combined Financing for Up to $180 Million

8 Aug 23

4:12pm

Filing search / Olema Pharmaceuticals, Inc. / "Responsible"

80 results

Top filers

Top filing types

Recent filing years